T-group (topology)
304.3.2 Peptide methionine sulfoxide reductase
Ligands and drugs
406
Member domains
28
with ligand contacts (≤ 4 Å)
6.9% of members
31
with DrugDomain annotations
7.6% of members
24
with a DrugBank compound
5.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 304.3.2 belongs to X-group 304 Alpha-beta plaits, which binds 8.8 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04447 | DTT | 1,4-Dithiothreitol | 4 |
| DB00145 | GLY | Glycine | 2 |
| DB02693 | D1D | (4S,5S)-1,2-dithiane-4,5-diol | 2 |
| DB02467 | MHO | L-methionine (S)-S-oxide | 1 |
| DB03345 | BME | Mercaptoethanol | 1 |
| DB08231 | MYR | Myristic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 4 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 3 |
| D1D | (4S,5S)-1,2-DITHIANE-4,5-DIOL | 2 |
| BME | BETA-MERCAPTOETHANOL | 1 |
| CAmetal | CALCIUM ION | 1 |
| CL | CHLORIDE ION | 1 |
| GLY | GLYCINE | 1 |
| MHO | S-OXYMETHIONINE | 1 |
| MYR | MYRISTIC ACID | 1 |
| SSM | (2S)-2-(acetylamino)-N-methyl-4-[(S)-methylsulfinyl]butanamide | 1 |